Ameditech ProScreen 8 Panel Dip Card Recalled for Reduced Benzodiazepine Reactivity
Ameditech is recalling 82 kits of ProScreen 8 Panel Dip Cards because they may show reduced reactivity for two specific benzodiazepine compounds.
The agency’s classification
FDA (Devices): Class III
Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class III, which is defined as unlikely to cause adverse health consequences. The issue is a performance defect (reduced reactivity) rather than a direct physical hazard, fitting the Moderate severity criteria for minor labeling or performance errors.
Plain-English summary
Ameditech Inc is recalling 82 kits of ProScreen 8 Panel Dip Card w/Adult, Item No. PSDA-8P, PSDA-8MBO300. The affected products were distributed nationwide.
The recall was initiated because the drugs of abuse tests showed reduced reactivity for up to two of the nineteen benzodiazepine compounds listed in the product insert. The specific compounds with potentially reduced reactivity are Clonazepam and Chlordiazepoxide.
The source text does not specify instructions for consumers or healthcare providers regarding the disposal or return of these kits.
The recalled product
- Product
- ProScreen 8 Panel Dip Card w/Adult, Item No. PSDA-8P, PSDA-8MBO300
- Manufacturer
- Ameditech Inc
- Affected units
- 82
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- 152950 152951 153325
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 59 recalled by Ameditech Inc under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 59 products in this recall →Related recalls
Same manufacturer · Ameditech Inc
See all →- ModerateAmeditech Noble 1 Step+ Cup Recalled for Inconsistent Performance
FDA (Devices) · 2020-10-07
- ModerateAmeditech iCup Dx14 Drug Screen Cup Recalled for Performance Failures
FDA (Devices) · 2020-10-07
- HighAmeditech Recalls ImmuTest Drugs of Abuse Cups for Performance Failures
FDA (Devices) · 2020-10-07
- ModerateAmeditech Fastect II Drug Screen Dipstick Tests Recalled for Performance Failures
FDA (Devices) · 2020-10-07
- ModerateAmeditech Recalls One Step + DOA Cup Due to Performance Failures
FDA (Devices) · 2020-10-07
Same hazard · reduced reactivity
See all →- ModerateSerology ToRCH positive control specimen recalled for decreased HSV reactivity
FDA (Devices) · 2024-01-10
- LowAmeditech DrugSmart Dip Benzodiazepine Test Recall for Reduced Reactivity
FDA (Devices) · 2015-12-30
- ModerateAmeditech ProScreen 6 Panel Dip Card Recall for Reduced Benzodiazepine Reactivity
FDA (Devices) · 2015-12-30
- ModerateAmeditech ProScreen 5 Panel Dip Card Recalled for Reduced Benzodiazepine Reactivity
FDA (Devices) · 2015-12-30
- ModerateAmeditech ProScreen 12 Drug Cup Recall for Reduced Benzodiazepine Reactivity
FDA (Devices) · 2015-12-30
Similar recalls
- ModerateAmeditech Recalls ProScreen Drug Panel Tests Due to Reduced Reactivity
FDA (Devices) · 2015-11-25
- HighAmeditech Recalls 11 Panel Dip Cards Due to Reduced Reactivity
FDA (Devices) · 2015-11-25
- ModerateAmeditech Recalls 6 Panel Drug Detection Cups Due to Reduced Reactivity
FDA (Devices) · 2015-11-25
- ModerateAmeditech Recalls QuickTox 5 Panel Drug Screen DipCard
FDA (Devices) · 2019-12-25
- ModerateAmeditech Recalls ArcPoint Labs 10 Panel Dip Screen Due to Reduced Reactivity
FDA (Devices) · 2015-11-25
- HighAmeditech Recalls Benzodiazepine Drug Abuse Tests Due to Reduced Reactivity
FDA (Devices) · 2015-11-25